Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06953934

A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants

Mass Balance Study of [14C] ABBV-932 Following Single Oral Dose Administration in Healthy Male Volunteers

Status
Not Yet Recruiting
Phase
Phase 1
Study type
Interventional
Enrollment
8 (estimated)
Sponsor
AbbVie · Industry
Sex
Male
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

The main objective of this study is to assess the safety and tolerability of ABBV-932 in healthy adult male participants.

Conditions

Interventions

TypeNameDescription
DRUGABBV-932Oral Capsule

Timeline

Start date
2025-10-14
Primary completion
2026-02-01
Completion
2026-02-01
First posted
2025-05-01
Last updated
2025-08-08

Source: ClinicalTrials.gov record NCT06953934. Inclusion in this directory is not an endorsement.

A Mass Balance Study of Oral [14C] ABBV-932 in Healthy Adult Male Participants (NCT06953934) · Clinical Trials Directory